Gestational diabetes needs to be managed

Michael C d’Emden, Narelle D Fagermo, Amanda J Love and Karin M C Lust
Med J Aust 2013; 198 (11): . || doi: 10.5694/mja13.10433
Published online: 17 June 2013

To the Editor: McIntyre and Oats1 suggest that Australian medical practitioners should adopt the new International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for the management of gestational diabetes mellitus (GDM),2 mainly because of the findings of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study.3 If adopted, a significant number of women will be diagnosed with GDM if their only blood glucose level (BGL) abnormality is a fasting BGL of 5.1–5.4 mmol/L. The quoted studies do not provide outcome data to confirm benefit at these levels.4,5 In addition, women currently diagnosed with GDM on the basis of a 2-hour BGL of more than 8.0 mmol/L but below the new IADPSG level of 8.5 mmol/L2 will no longer meet the criteria. But outcome data show a benefit of management at these levels.4 Also, the US study on treatment for mild GDM used a 100 g oral glucose tolerance test (OGTT)5 with a 2-hour BGL cut-off that approximates 8.0 mmol/L on a 75 g OGTT.6 Thus the two quoted outcome studies demonstrate benefit of treatment at BGLs that will no longer be accepted for the diagnosis of GDM.

  • Michael C d’Emden
  • Narelle D Fagermo
  • Amanda J Love
  • Karin M C Lust

  • Royal Brisbane and Women’s Hospital, Brisbane, QLD.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.